Singapore, July 28 -- AI Medical Service Inc (AIM), a Japan-based medical startup specialising in the development of diagnostic endoscopic AI, has received medical device approval from the Thai Food and Drug Administration (Thai FDA).

The approval is for its endoscopic image diagnosis support software, the "gastroAI-model G." This system utilises artificial intelligence (AI) to assist physicians in differentiating between neoplastic and non-neoplastic gastric lesions within endoscopic images.

This marks the first time in Thailand that an AI-powered diagnostic support system for the upper gastrointestinal tract, equipped with lesion differentiationcapabilities, has received regulatory approval.

In Thailand, the high mortality rate for g...